Estíbaliz Miranda
Chartered Institute of Management Accountants(GB)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Histone Deacetylase Inhibitors Research, Epigenetics and DNA Methylation, Acute Myeloid Leukemia Research
Most-Cited Works
- → Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression(2019)187 cited
- → Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies(2017)166 cited
- → An in-silico approach to predict and exploit synthetic lethality in cancer metabolism(2017)64 cited
- → Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy(2018)61 cited
- → Frequent and Simultaneous Epigenetic Inactivation of TP53 Pathway Genes in Acute Lymphoblastic Leukemia(2011)57 cited
- → Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma(2020)53 cited
- → Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma(2021)49 cited
- → Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia(2012)44 cited
- → Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulated(2019)35 cited
- → Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces(2018)32 cited